Skip to content

To explore the real world study of acupotomy-knife treatment of ankylosing spondylitis under the guidance of meridian tendon theory and to establish a prediction model for efficacy evaluation

To explore the real world study of acupotomy-knife treatment of ankylosing spondylitis under the guidance of meridian tendon theory and to establish a prediction model for efficacy evaluation

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400091377
Enrollment
Unknown
Registered
2024-10-28
Start date
2023-05-03
Completion date
Unknown
Last updated
2024-11-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ankylosing Spondylitis

Interventions

Ankylosing spondylitis group:Needle-knife

Sponsors

Dongzhimen Hospital Affliated to Beijing University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1.Age 18-65 years old; Gender is not limited; 2.Axial spondyloarthritis (SpA) classification criteria recommended by the ankylosing Spondylitis Assessment Task Force (ASAS) in 2009. 3. The patient had pain, stiffness, and limitation of movement in the cervical, thoracic, and lumbar vertebrae; 4.The use of slow-acting antirheumatic drugs such as sulfasalazine, methotrexate, leflunomide must be in a stable dose for at least one month, otherwise the drug must be stopped for at least one month; 5.Those who had not used nsaids within 2 weeks before enrollment; 6.Patients who had not used biologics within 3 months before enrollment were eligible if they used biologics steadily for 1 month; 7.Those who did not participate in any TCM non-drug trial within 4 weeks before enrollment; 8.Voluntarily participate in the study and sign informed consent.

Exclusion criteria

Exclusion criteria: 1. Pregnant, preparing to become pregnant, or breastfeeding women; 2. Patients with previous or current history of malignant tumors; 3. People with acute and/or chronic infectious diseases; 4.Patients with adverse reactions during acupotomology treatment in the past; 5.Patients who had been diagnosed with other rheumatic diseases; 6. Patients who had been treated with needle knife in the past but the condition was not controlled; 7. Those who were deemed by the investigator to be ineligible for enrollment in the trial.

Design outcomes

Primary

MeasureTime frame
Neck Disabilitv Index,NDI;

Secondary

MeasureTime frame
Oswestry disability index lumbar function grading;Ankylosing Spondylitis sessment in Ankylosing Spondylitis international Society20 score;Bath Ankylosing Spondylitis disease activity index score;Bath Ankylosing spondylitis functional activity quantitative index score;erythrocyte sedimentation Rate;C-reactive protein;

Countries

China

Contacts

Public ContactHailong Wang

Dongzhimen Hospital Affliated to Beijing University of Chinese Medicine(Beijing Tongzhou District Hospital of Traditional Chinese Medicine)

wang.hailong@139.com+86 130 2104 4721

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026